# US 2012/0232458 A1 · Implantable systems and methods for removing specific impurities from fluids such as blood

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0232458 A1
- Document ID: US20120232458A1
- Status: Published application
- Kind: A1
- Application number: 13/044,147
- Filed: 2011-03-09
- Published: 2012-09-13
- Earliest claimed: 2011-03-09
- Inventors: Zvi Herschman
- Web page: https://patentgrep.com/patent/US20120232458A1

## CPC

- A61M 1/1678: {intracorporal (peritoneal dialysis A61M1/28)}
- A61F 2/022: {Artificial gland structures using bioreactors (hemodialysis A61M1/16; hemofiltration A61M1/34; other extracorporeal blood treatment A61M1/36)}
- A61M 1/3417: {using distinct filters for dialysis and ultra-filtration}
- B01D 61/42: Electrodialysis; Electro-osmosis {; Electro-ultrafiltration; Membrane capacitive deionization}
- A61F 2230/0069: cylindrical
- A61F 2250/0001: Means for transferring electromagnetic energy to implants
- A61F 2250/0023: differing in porosity
- A61F 2250/0024: made from both porous and non-porous parts, e.g. adjacent parts
- A61F 2250/0043: differing in electric properties, e.g. in electrical conductivity, in galvanic properties
- B01D 57/02: by electrophoresis (treatment of water, waste water, sewage or sludge by electrophoresis C02F1/469; electrophoretic production of compounds or non-metals C25B7/00; investigating or analysing materials by using electrophoresis G01N27/26)
- B01D 61/44: Ion-selective electrodialysis
- B01D 61/52: Accessories; Auxiliary operation
- B01D 61/54: Controlling or regulating
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- B01D: SEPARATION (separating solids from solids by wet methods B03B, B03D; by pneumatic jigs or tables B03B; by other dry methods B07; magnetic or electrostatic separation of solid materials from solid materials or fluids, separation by high-voltage electric fields B03C; centrifuges, vortex apparatus B04; presses per se for squeezing-out liquid from liquid-containing material B30B9/02; treatment of water C02F, e.g. softening by ion-exchange C02F1/42; {arrangements of air intake cleaners in gas turbine plants F02C7/05} ; arrangements or mounting of filters in air-conditioning, air-humidification or ventilation F24F13/28)

## Abstract

Systems and methods utilize semipermeable nanotubes in conjunction with application of controlled electrical potentials across semipermeable nanotube walls allow selective transport of charged impurities (e.g., charged impurities, ions, etc.) from a fluid into these nanotubes. Impurities collected in these nanotubes can then be removed from the fluid, (e.g., blood) as a waste stream. A collection of semipermeable nanotubes each carrying a waste stream can be aggregated and merged into a ureter for excretion thereby providing an artificial kidney system. Sensors that detect/measure various impurities may be included in the system to feed information to a microprocessor to inform on concentrations of impurities, and thereby control electrical potentials applied to the system.

## Claims

### Claim 1

A system for removing impurities from a fluid, comprising:
at least one semipermeable nanostructure assembly having a plurality of pores through which at least some of the impurities may be transported;
an enclosure containing at least one semipermeable nanostructure assembly, the enclosure providing a fluid path through which at least some of the fluid may flow; and
wherein an electric field is generated to transport at least some of the impurities in the fluid through the plurality of pores in the at least one semipermeable nanostructure assembly, thereby removing those impurities from the fluid.

### Claim 2 (depends on 1)

The system of claim 1, wherein at least some of the impurities removed from the fluid are at least one of (i) captured within the at least one semipermeable nanostructure assembly and (ii) removed from the system as a waste stream.

### Claim 3 (depends on 1)

The system of claim 1, wherein the at least one semipermeable nanostructure assembly further comprises a plurality of semipermeable nanostructures assembled to form an array.

### Claim 4 (depends on 3)

The system of claim 3, wherein at least some of the plurality of semipermeable nanostructures forming the array are aligned substantially in parallel.

### Claim 5 (depends on 3)

The system of claim 3, wherein the at least one semipermeable nanostructure assembly further comprises at least one semipermeable nanotube.

### Claim 6 (depends on 3)

The system of claim 3, further comprising:
at least one sensor for monitoring the amount of at least one impurity within the fluid.

### Claim 7 (depends on 6)

The system of claim 6, further comprising:
at least one microprocessor that regulates the electric field by analyzing information obtained from the at least one sensor.

### Claim 8 (depends on 6)

The system of claim 6, wherein the at least one sensor utilizes at least one of either an electrochemical and optical detection system.

### Claim 9 (depends on 7)

The system of claim 7, wherein the electric field is generated by either a fixed or variable voltage waveform.

### Claim 10 (depends on 1)

The system of claim 1, wherein the at least one semipermeable nanostructure assembly is constructed from materials comprising at least one of carbon, polymers, cross-linked polymers, inorganic compounds, inorganic polymers, metals, and organic compounds.

### Claim 11 (depends on 7)

The system of claim 7, wherein the at least one microprocessor utilizes the output from at least one sensor to adjust the electric field in accordance with the monitored impurity level.

### Claim 12 (depends on 1)

The system of claim 1, wherein the plurality of pores are dimensioned to allow passage of specific impurities.

### Claim 13

An artificial kidney system for removing impurities from a bodily fluid, comprising:
at least one semipermeable nanostructure assembly having a plurality of pores through which at least some of these impurities may be transported;
an enclosure containing the at least one semipermeable nanostructure assembly, the enclosure providing a fluid path through which at least some of the bodily fluid may flow; and
wherein an electric field is generated to transport at least some of the impurities in the bodily fluid through the plurality of pores in the at least one semipermeable nanostructure assembly, thereby removing those impurities from the bodily fluid.

### Claim 14 (depends on 13)

The artificial kidney system of claim 13, wherein the bodily fluid is blood.

### Claim 15 (depends on 13)

The artificial kidney system of claim 13, wherein at least some of the impurities removed from the bodily fluid are at least one of (i) captured within the at least one semipermeable nanostructure assembly; (ii) removed from the system as a waste stream; and (iii) removed from the system as a waste stream flowing to the bodies ureter.

### Claim 16 (depends on 13)

The artificial kidney system of claim 13, wherein the at least one semipermeable nanostructure assembly further comprises a plurality of semipermeable nanostructures assembled to form an array.

### Claim 17 (depends on 16)

The artificial kidney system of claim 16, wherein at least some of the plurality of semipermeable nanostructures forming the array are aligned substantially in parallel.

### Claim 18 (depends on 13)

The artificial kidney system of claim 13, wherein the at least one semipermeable nanostructure assembly further comprises at least one semipermeable nanotube.

### Claim 19 (depends on 13)

The artificial kidney system of claim 13, further comprising:
at least one sensor for monitoring the amount of at least one impurity within the bodily fluid.

### Claim 20 (depends on 19)

The artificial kidney system of claim 19, further comprising:
at least one microprocessor that regulates the electric field by analyzing information obtained from at least one sensor.

### Claim 21 (depends on 19)

The artificial kidney system of claim 19, wherein the at least one sensor utilizes at least one of electrochemical and optical detection.

### Claim 22 (depends on 20)

The artificial kidney system of claim 20, wherein the electric field is generated by either a fixed or variable voltage waveform.

### Claim 23 (depends on 20)

The artificial kidney system of claim 20, wherein the at least one microprocessor utilizes the at least one sensor to adjust the electric field in accordance with the monitored impurity level.

### Claim 24 (depends on 13)

The artificial kidney system of claim 13, wherein the bodily fluid to be purified enters the system from at least one of an artery and a vein and exits the system by flowing to at least one of the same artery, a different artery, the same vein, and a different vein.

### Claim 25 (depends on 13)

The artificial kidney system of claim 13, wherein the electric field is generated by an energy source that is at least one of (i) an implanted battery and (ii) a biological fuel cell utilizing glucose potential gradients normally occurring in blood.

### Claim 26 (depends on 13)

The artificial kidney system of claim 13, wherein the at least one semipermeable nanostructure assembly is constructed from materials comprising at least one of carbon, polymers, cross-linked polymers, inorganic compounds, metals, or organic compounds.

### Claim 27 (depends on 13)

The artificial kidney system of claim 13, wherein one or more anticoagulants are attached to one or more surfaces of the system that contact the bodily fluid.

### Claim 28 (depends on 13)

The artificial kidney system of claim 13, wherein the plurality of pores are dimensioned to pass water and impurities while red blood cells or other large blood constituents are excluded.

### Claim 29 (depends on 13)

The artificial kidney system of claim 13, wherein the artificial kidney system is configured and dimensioned to be implantable with a human body.

### Claim 30

A method for removing impurities from a fluid, comprising the steps of:
providing at least one semipermeable nanostructure assembly having a plurality of pores through which at least some of the impurities are capable of being transported;
providing a fluid path through which at least some of the fluid flows along the at least one semipermeable nanostructure assembly; and
generating an electric field to transport at least some of the impurities in the fluid through the pores of the at least one semipermeable nanostructure assembly, thereby removing those impurities from the fluid in the fluid path.

### Claim 31 (depends on 30)

The method of claim 30, further comprising collecting the impurities transported through the pores of the at least one semipermeable nanostructure assembly to form a separate waste stream.

### Claim 32 (depends on 30)

The method of claim 30, wherein the step of providing at least one semipermeable nanostructure assembly further comprises the steps of:
providing a plurality of semipermeable nanostructures; and
assembling the plurality of semipermeable nanostructures to form an array.

### Claim 33 (depends on 30)

The method of claim 30, wherein the at least one semipermeable nanostructure assembly further comprises at least one semipermeable nanotube.

### Claim 34 (depends on 30)

The method of claim 30, further comprising the step of providing at least one sensor to monitor the impurities that are transported by the electric field through the at least one semipermeable nanostructure assembly.

### Claim 35 (depends on 34)

The method of claim 34, further comprising the step of regulating the electric field by analyzing information obtained from the at least one sensor.

### Claim 36 (depends on 35)

The method of claim 35, wherein the step of regulating the electric field further comprises the step of regulating the electric field by use of either a fixed or variable voltage waveform.

### Claim 37 (depends on 34)

The method of claim 34, further comprising the step of adjusting the electric field in accordance with the detected monitored impurity levels.

### Claim 38 (depends on 30)

The method of claim 30, further comprising the step of dimensioning the plurality of pores to pass specific impurities.

### Claim 39 (depends on 30)

The method of claim 30, further comprising the step of attaching one or more anticoagulants to one or more surfaces that contact the bodily fluid.

### Claim 40 (depends on 30)

The method of claim 30, further comprising collecting the impurities transported through the pores of the at least one semipermeable nanostructure assembly to form a separate waste stream flowing to the bodies ureter.
